Stock listing
Oncodesign Precision Medicine S.a.
Selected listing: A3DVNM · LS · EUR · DE
Oncodesign Precision Medicine S.a. (Lang & Schwarz: A3DVNM), Health Technology. Latest release Apr 30, 2026: OPM Announces Its 2025 Annual Results…
- Ticker
- Lang & Schwarz: A3DVNM
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Oncodesign Precision Medicine S.a.
OPM Announces Its 2025 Annual Results and Provides an Update on Its Clinical Developments
April 30, 2026
Oncodesign Precision Medicine Receives Support from The Michael J. Fox Foundation to Advance Development of LRRK2 Inhibitor OPM-201 for Parkinson’s Disease
March 3, 2026
Oncodesign Precision Medicine and Ksilink Join Forces to Test the Nanocyclix® Chemical Library in Cell Models Derived From Patients With Serious Central Nervous System Diseases
January 8, 2026
Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics
December 29, 2025
OPM Obtains Development Grants From the Bourgogne Franche-Comté Region
October 14, 2025
Research Oncodesign Precision Medicine S.a.
Oncodesign Precision Medicine S.a. company profile
View the public company page for Oncodesign Precision Medicine S.a. on 6ix.
Oncodesign Precision Medicine S.a. news
Read company news and market updates connected to Oncodesign Precision Medicine S.a..
Oncodesign Precision Medicine S.a. investor events
Find investor webinars, events, and replay context for Oncodesign Precision Medicine S.a..
Alternate listings
ALOPM:EURONEXT
FR · EUR
Alternate listing for Oncodesign Precision Medicine S.a.; the primary context on this page is A3DVNM:LS.
A3DVNM:LSX
DE · EUR
Alternate listing for Oncodesign Precision Medicine S.a.; the primary context on this page is A3DVNM:LS.
ZR8:FWB
DE · EUR
Alternate listing for Oncodesign Precision Medicine S.a.; the primary context on this page is A3DVNM:LS.
ZR8:SWB
DE · EUR
Alternate listing for Oncodesign Precision Medicine S.a.; the primary context on this page is A3DVNM:LS.